Pathway Genomics, Susan G. Komen Partner on Breast Cancer Screening | GenomeWeb

NEW YORK (GenomeWeb News) – Pathway Genomics and Susan G. Komen today said they are partnering to educate women about screening options available for detecting a genetic predisposition for breast cancer.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.